AstraZeneca cancer drug trial prompts investors to take options cover By: Reuters: Company News June 27, 2017 at 13:04 PM EDT * U.S. near-term put contracts outweigh call options 3.3 times Read More >> Related Stocks: Astrazeneca Plc ADR Bristol-Myers Squibb Merck & Co Rogers Corp